Houston Methodist and Purdue University Make a Breakthrough That May Result in a More Effective Tuberculosis Vaccine

A recombinant bovine adenoviral mucosal vaccine expressing mycobacterial antigen-85B generates robust protection against tuberculosis in mice

Houston Methodist Researchers Generate and Validate Humanized Biomimetic Nanovesicles to Target Neurons – Two Firsts in Nanovesicle Theranostics

In a paper recently published in Advanced Science, Houston Methodist researchers successfully targeted human neurons in vitro with humanized biomimetic nanovesicles in an effort to improve specificity of neuro theranostics.